<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="155">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on March 04, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04793672</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-2019-56</org_study_id>
    <nct_id>NCT04793672</nct_id>
  </id_info>
  <brief_title>Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis</brief_title>
  <official_title>A Multi-center Observational Clinical Study Observing the Differences of Tongue Images Between Patients With Malignant Tumors and Healthy People</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhejiang Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhejiang Cancer Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The tongue images of malignant tumors and corresponding healthy people will be collected to&#xD;
      establish the tongue image database. Deep learning will be carried out by computer and&#xD;
      artificial intelligence to construct the early screening, diagnosis, prognosis and prognosis&#xD;
      model of various malignant tumors based on tongue image for the diagnosis and treatment of&#xD;
      malignant tumors.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 6, 2021</start_date>
  <completion_date type="Anticipated">February 2, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>The differences of tongue images between patients with malignant tumors and healthy people.</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Survival (OS)</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease free survival（DFS）</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Malignant Tumor</condition>
  <arm_group>
    <arm_group_label>Patients with malignant tumors and healthy people</arm_group_label>
    <description>Tongue images, coating on the tongue and clinical data of patients with malignant tumors and healthy people will be collected.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Tongue images, coating on the tongue and clinical data of patients with malignant tumors and healthy people will be collected.</intervention_name>
    <description>Tongue images, coating on the tongue and clinical data of patients with malignant tumors and healthy people will be collected.</description>
    <arm_group_label>Patients with malignant tumors and healthy people</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Histologically or cytologically confirmed malignant tumor，and no prior chemotherapy,&#xD;
        radiotherapy, biotherapy, immunotherapy or other anti-tumor treatment for malignant tumor.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18≤age≤80&#xD;
&#xD;
          -  Histologically or cytologically confirmed malignant tumor&#xD;
&#xD;
          -  No prior chemotherapy, radiotherapy, biotherapy, immunotherapy or other anti-tumor&#xD;
             treatment for malignant tumor&#xD;
&#xD;
          -  Subject volunteers to join the study, Signs informed consent, has good compliance and&#xD;
             can cooperate with follow-up&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Two or more kinds of malignant tumors at the same time&#xD;
&#xD;
          -  Malignant tumor that has been treated by chemotherapy, radiotherapy, biotherapy,&#xD;
             immunotherapy or other anti-tumor therapy&#xD;
&#xD;
          -  Subjects who had other factors that might force them to terminate the research ahead&#xD;
             of time, such as the development of other severe disease (including mental disease)&#xD;
             that required combined treatment, seriously abnormal laboratory examination value, and&#xD;
             family or social factors that might affect the subject safety or experimental data&#xD;
             collection, as judged by the researchers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiangdong Cheng, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhejiang Cancer Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiangdong Cheng, MD</last_name>
    <phone>0086-571-88128041</phone>
    <email>Chengxd516@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhiyuan Xu, MD</last_name>
    <phone>0086-571-88128041</phone>
    <email>getfar@foxmai.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310022</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiangdong Cheng, MD</last_name>
      <phone>+0086-0571-88128041</phone>
      <email>Chengxd516@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhejiang Cancer Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310022</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheng Xiangdong, MD</last_name>
      <phone>+0086-571-88128041</phone>
      <email>Chengxd516@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 5, 2021</study_first_submitted>
  <study_first_submitted_qc>March 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 11, 2021</study_first_posted>
  <last_update_submitted>April 23, 2021</last_update_submitted>
  <last_update_submitted_qc>April 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zhejiang Cancer Hospital</investigator_affiliation>
    <investigator_full_name>Xiangdong Cheng</investigator_full_name>
    <investigator_title>Professor; Chief physician</investigator_title>
  </responsible_party>
  <keyword>Malignant tumor</keyword>
  <keyword>Tongue Image</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

